{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:09:13Z","timestamp":1780492153217,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11096-016-0272-y","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T06:21:26Z","timestamp":1456899686000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression"],"prefix":"10.1007","volume":"38","author":[{"given":"Amany K.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy C.","family":"Brahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara R.","family":"Neas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"issue":"23","key":"272_CR1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095\u2013105.","journal-title":"JAMA"},{"issue":"8","key":"272_CR2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","volume":"53","author":"M Fava","year":"2003","unstructured":"Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649\u201359.","journal-title":"Biol Psychiatry"},{"key":"272_CR3","unstructured":"American Psychiatric Association (Internet). Practice guidelines for the treatment of patients with major depressive disorder (cited 2015, July 8). http:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf (2010)."},{"issue":"11","key":"272_CR4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1176\/ajp.2006.163.11.1864","volume":"163","author":"JC Nelson","year":"2006","unstructured":"Nelson JC. The STAR*D study: a four-course meal that leaves us wanting more. Am J Psychiatry. 2006;163(11):1864\u20136.","journal-title":"Am J Psychiatry"},{"issue":"Suppl","key":"272_CR5","first-page":"39","volume":"51","author":"AA Nierenberg","year":"1990","unstructured":"Nierenberg AA, Amsterdam JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry. 1990;51(Suppl):39\u201347 (discussion 48\u201350).","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"272_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11530280-000000000-00000","volume":"24","author":"RC Shelton","year":"2010","unstructured":"Shelton RC, Osuntokun O, Heinloth AN, Corya SA. Therapeutic options for treatment-resistant depression. CNS Drugs. 2010;24(2):131\u201361.","journal-title":"CNS Drugs"},{"key":"272_CR7","unstructured":"National Guideline Clearinghouse (Internet). Diagnosis and treatment of depression in adults: 2012 clinical practice guidelines (cited 2015, Oct 9). http:\/\/www.guideline.gov\/content.aspx?id=39432 (2012)."},{"issue":"Suppl 16","key":"272_CR8","first-page":"18","volume":"62","author":"SG Kornstein","year":"2001","unstructured":"Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry. 2001;62(Suppl 16):18\u201325.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"272_CR9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.288.11.1403","volume":"288","author":"SA Bull","year":"2002","unstructured":"Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, et al. Discontinuation of use and switching of antidepressants: influence of patient\u2013physician communication. JAMA. 2002;288(11):1403\u20139.","journal-title":"JAMA"},{"issue":"8 Suppl 13","key":"272_CR10","first-page":"1","volume":"12","author":"MH Trivedi","year":"2007","unstructured":"Trivedi MH, Lin EH, Katon WJ. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. CNS Spectr. 2007;12(8 Suppl 13):1\u201327.","journal-title":"CNS Spectr"},{"issue":"11","key":"272_CR11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/00023210-200822110-00005","volume":"22","author":"DV Sheehan","year":"2008","unstructured":"Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and\/or anxiety disorders. CNS Drugs. 2008;22(11):963\u201373.","journal-title":"CNS Drugs"},{"issue":"2","key":"272_CR12","first-page":"146","volume":"21","author":"JL Givens","year":"2006","unstructured":"Givens JL, Datto CJ, Ruckdeschel K, Knott K, Zubritsky C, Oslin DW, et al. Older patients\u2019 aversion to antidepressants. A qualitative study. J Gen Intern Med. 2006;21(2):146\u201351.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"272_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4088\/PCC.v09n0202","volume":"9","author":"VM Hunot","year":"2007","unstructured":"Hunot VM, Horne R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91\u20139.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"9","key":"272_CR14","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","volume":"25","author":"S Karve","year":"2009","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25(9):2303\u201310.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"272_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565\u201374 (discussion 575\u2013567).","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"272_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0b013e328343ba1e","volume":"26","author":"X Liu","year":"2011","unstructured":"Liu X, Tepper PG, Able SL. Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder. Int Clin Psychopharmacol. 2011;26(3):173\u201380.","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"272_CR17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/da.21952","volume":"29","author":"CH Wu","year":"2012","unstructured":"Wu CH, Farley JF, Gaynes BN. The association between antidepressant dosage titration and medication adherence among patients with depression. Depress Anxiety. 2012;29(6):506\u201314.","journal-title":"Depress Anxiety"},{"issue":"5","key":"272_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"272_CR19","first-page":"370","volume":"16","author":"TB Gibson","year":"2010","unstructured":"Gibson TB, Jing Y, Smith Carls G, Kim E, Bagalman JE, Burton WN, et al. Cost burden of treatment resistance in patients with depression. Am J Manag Care. 2010;16(5):370\u20137.","journal-title":"Am J Manag Care"},{"issue":"4","key":"272_CR20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.jcp.0000169036.40755.16","volume":"25","author":"T Petersen","year":"2005","unstructured":"Petersen T, Papakostas GI, Posternak MA, KantA GuykerWM, Iosifescu DV, et al. Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol. 2005;25(4):336\u201341.","journal-title":"J Clin Psychopharmacol"},{"issue":"1\u20133","key":"272_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2010.06.036","volume":"127","author":"R Correa","year":"2010","unstructured":"Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M, Zisook S. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord. 2010;127(1\u20133):10\u20138.","journal-title":"J Affect Disord"},{"issue":"1","key":"272_CR22","first-page":"21","volume":"44","author":"G Vazquez","year":"2011","unstructured":"Vazquez G, Tondo L, Baldessarini RJ. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. Pharmacopsychiatry. 2011;44(1):21\u20136.","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"272_CR23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","volume":"63","author":"WH Crown","year":"2002","unstructured":"Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry. 2002;63(11):963\u201371.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"272_CR24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.v65n0309","volume":"65","author":"JM Russell","year":"2004","unstructured":"Russell JM, Hawkins K, Ozminkowski RJ, Orsini L, Crown W, Kennedy S, et al. The cost consequences of treatment-resistant depression. J Clin Psychiatry. 2004;65(3):341\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"272_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00019053-200422060-00003","volume":"22","author":"P Greenberg","year":"2004","unstructured":"Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics. 2004;22(6):363\u201373.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"272_CR26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.clinthera.2011.07.015","volume":"33","author":"Y Jing","year":"2011","unstructured":"Jing Y, Kalsekar I, Curkendall SM, Carls GS, Bagalman E, Forbes RA, et al. Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression. Clin Ther. 2011;33(9):1246\u201357.","journal-title":"Clin Ther"},{"issue":"2","key":"272_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.287.2.203","volume":"287","author":"M Olfson","year":"2002","unstructured":"Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA. 2002;287(2):203\u20139.","journal-title":"JAMA"},{"issue":"12","key":"272_CR28","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archgenpsychiatry.2011.146","volume":"68","author":"CA Fullerton","year":"2011","unstructured":"Fullerton CA, Busch AB, Normand SL, McGuire TG, Epstein AM. Ten-year trends in quality of care and spending for depression: 1996 through 2005. Arch Gen Psychiatry. 2011;68(12):1218\u201326.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"272_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.2051-5545.2008.tb00154.x","volume":"7","author":"A Ucok","year":"2008","unstructured":"Ucok A, Gaebel W. Side effects of atypical antipsychotics: a brief overview. World Psychiatry. 2008;7(1):58\u201362.","journal-title":"World Psychiatry"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-016-0272-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0272-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:55Z","timestamp":1559368495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-016-0272-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1007\/s11096-016-0272-y","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}